NCT05137197 Confirm the Effectiveness of Predictix Genetics Antidepressant -Guided Treatment in Adults With MDD Status UNKNOWN Phase NA
NCT05136755 NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder Status RECRUITING Phase PHASE2
NCT05135897 The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments Status RECRUITING Phase N/A
NCT05134103 Mindbeacon Therapist Assisted Internet Delivered CBT for Depression Status WITHDRAWN Phase NA
NCT05118594 Testing a Precision Psychotherapy System for Low-income Patients Status NOT_YET_RECRUITING Phase NA
NCT05104918 Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities Status UNKNOWN Phase PHASE3
NCT05086120 A Remote Electronically Delivered Integrated Care Pathway: A Feasibility Study Status TERMINATED Phase NA
NCT05084924 Investigating the Causal Role of Prefrontal Control in Decision-making in Patients With Anhedonia Status COMPLETED Phase NA
NCT05081167 A Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE3
NCT05061719 An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT05061706 Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT05054699 Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05051618 Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis Status RECRUITING Phase NA